BACKGROUND: To assess national practice patterns regarding use of perioperative antibiotics by surgeons performing breast operations requiring drainage tubes. METHODS: The members of the American Society of Breast Surgeons (ASBrS) were surveyed regarding use of perioperative antibiotics for breast operations requiring drains, with or without immediate tissue expander or implant reconstruction. RESULTS: Of 2,857 ASBrS members contacted, 917 (32 %) responded; all self-identified as surgeons. Of 905 evaluable respondents, most described themselves as general surgeons (46 %) or breast surgeons (46 %). For cases in which drains are anticipated, most respondents (86 %) reported routine use of preoperative prophylactic antibiotics, with 99 % selecting cephalosporins. Use of antibiotic >24 h postoperatively varied by whether or not reconstruction was performed. In nonreconstruction cases, the majority (76 %) reported "never/almost never" prescribing antibiotics beyond the 24-h postoperative period, but 16 % reported "always/almost always." In reconstruction cases, the majority (58 %) reported routine antibiotic use beyond 24 h, and the primary driver of the decision to use antibiotics was reported to be the plastic surgeon (83 %). Among those reporting use at >24 h, the duration recommended for nonreconstruction cases was "up to 1 week" in 38 % and "until drains removed" in 39 %; this was similar for reconstruction cases. CONCLUSIONS: Cephalosporins are utilized uniformly as preoperative antibiotic prophylaxis in breast operations requiring drains. However, use of postoperative antibiotic prophylaxis is strongly dependent on the presence of immediate breast reconstruction. Consensus is lacking on the role of postoperative antibiotic prophylaxis in breast operations utilizing drains.
BACKGROUND: To assess national practice patterns regarding use of perioperative antibiotics by surgeons performing breast operations requiring drainage tubes. METHODS: The members of the American Society of Breast Surgeons (ASBrS) were surveyed regarding use of perioperative antibiotics for breast operations requiring drains, with or without immediate tissue expander or implant reconstruction. RESULTS: Of 2,857 ASBrS members contacted, 917 (32 %) responded; all self-identified as surgeons. Of 905 evaluable respondents, most described themselves as general surgeons (46 %) or breast surgeons (46 %). For cases in which drains are anticipated, most respondents (86 %) reported routine use of preoperative prophylactic antibiotics, with 99 % selecting cephalosporins. Use of antibiotic >24 h postoperatively varied by whether or not reconstruction was performed. In nonreconstruction cases, the majority (76 %) reported "never/almost never" prescribing antibiotics beyond the 24-h postoperative period, but 16 % reported "always/almost always." In reconstruction cases, the majority (58 %) reported routine antibiotic use beyond 24 h, and the primary driver of the decision to use antibiotics was reported to be the plastic surgeon (83 %). Among those reporting use at >24 h, the duration recommended for nonreconstruction cases was "up to 1 week" in 38 % and "until drains removed" in 39 %; this was similar for reconstruction cases. CONCLUSIONS:Cephalosporins are utilized uniformly as preoperative antibiotic prophylaxis in breast operations requiring drains. However, use of postoperative antibiotic prophylaxis is strongly dependent on the presence of immediate breast reconstruction. Consensus is lacking on the role of postoperative antibiotic prophylaxis in breast operations utilizing drains.
Authors: Alyssa D Throckmorton; Larry M Baddour; Tanya L Hoskin; Judy C Boughey; Amy C Degnim Journal: Surg Infect (Larchmt) Date: 2010-08 Impact factor: 2.150
Authors: Jonathan R Edwards; Kelly D Peterson; Yi Mu; Shailendra Banerjee; Katherine Allen-Bridson; Gloria Morrell; Margaret A Dudeck; Daniel A Pollock; Teresa C Horan Journal: Am J Infect Control Date: 2009-12 Impact factor: 2.918
Authors: Brett T Phillips; Eric D Wang; Joshua Mirrer; Steven T Lanier; Sami U Khan; Alexander B Dagum; Duc T Bui Journal: Ann Plast Surg Date: 2011-05 Impact factor: 1.539
Authors: Catherine de Blacam; Adeyemi A Ogunleye; Adeyiza O Momoh; Salih Colakoglu; Adam M Tobias; Ranjna Sharma; Mary Jane Houlihan; Bernard T Lee Journal: Ann Surg Date: 2012-03 Impact factor: 12.969
Authors: E Prospero; A Cavicchi; S Bacelli; P Barbadoro; L Tantucci; M M D'Errico Journal: Infect Control Hosp Epidemiol Date: 2006-11-21 Impact factor: 3.254
Authors: Alyssa D Throckmorton; Judy C Boughey; Sarah Y Boostrom; Andrea C Holifield; Melissa M Stobbs; Tanya Hoskin; Larry M Baddour; Amy C Degnim Journal: Ann Surg Oncol Date: 2009-06-09 Impact factor: 5.344
Authors: Margaret A Olsen; Mellani Lefta; Jill R Dietz; Keith E Brandt; Rebecca Aft; Ryan Matthews; Jennie Mayfield; Victoria J Fraser Journal: J Am Coll Surg Date: 2008-06-26 Impact factor: 6.113
Authors: Leigh Neumayer; Tracy L Schifftner; William G Henderson; Shukri F Khuri; Mahmoud El-Tamer Journal: J Am Coll Surg Date: 2007-06 Impact factor: 6.113
Authors: Amy C Degnim; Tanya L Hoskin; Rushin D Brahmbhatt; Anne Warren-Peled; Margie Loprinzi; Emily S Pavey; Judy C Boughey; Tina J Hieken; Steven Jacobson; Valerie Lemaine; James W Jakub; Chetan Irwin; Robert D Foster; Hani Sbitany; Michel Saint-Cyr; Erin Duralde; Sheri Ramaker; Robin Chin; Monica Sieg; Melissa Wildeman; Jeffrey S Scow; Robin Patel; Karla Ballman; Larry M Baddour; Laura J Esserman Journal: Ann Surg Oncol Date: 2014-08-06 Impact factor: 5.344
Authors: Florian Ebner; Niko deGregorio; Elena Vorwerk; Wolfgang Janni; Achim Wöckel; Dominic Varga Journal: Breast Care (Basel) Date: 2014-05 Impact factor: 2.860
Authors: Amy C Degnim; Jeffrey S Scow; Tanya L Hoskin; Joyce P Miller; Margie Loprinzi; Judy C Boughey; James W Jakub; Alyssa Throckmorton; Robin Patel; Larry M Baddour Journal: Ann Surg Date: 2013-08 Impact factor: 12.969
Authors: Margaret A Olsen; Katelin B Nickel; Victoria J Fraser; Anna E Wallace; David K Warren Journal: Infect Control Hosp Epidemiol Date: 2017-07-03 Impact factor: 3.254
Authors: David K Warren; Katelin B Nickel; Christopher J Hostler; Katherine Foy; Jennifer H Han; Pam Tolomeo; Ian R Banks; Victoria J Fraser; Margaret A Olsen Journal: Infect Control Hosp Epidemiol Date: 2020-10-12 Impact factor: 3.254